Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The antimicrobial effect of Iseganan HCl oral solution in patients receiving stomatotoxic chemotherapy: analysis from a multicenter, double-blind, placebo-controlled, randomized, phase III clinical trial.

Elad S, Epstein JB, Raber-Durlacher J, Donnelly P, Strahilevitz J.

J Oral Pathol Med. 2012 Mar;41(3):229-34. doi: 10.1111/j.1600-0714.2011.01094.x. Epub 2011 Nov 14.

PMID:
22077420
2.

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).

Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ; PROMPT-CT Trial Investigators.

Leuk Lymphoma. 2003 Jul;44(7):1165-72.

PMID:
12916869
3.

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.

Giles FJ, Rodriguez R, Weisdorf D, Wingard JR, Martin PJ, Fleming TR, Goldberg SL, Anaissie EJ, Bolwell BJ, Chao NJ, Shea TC, Brunvand MM, Vaughan W, Petersen F, Schubert M, Lazarus HM, Maziarz RT, Silverman M, Beveridge RA, Redman R, Pulliam JG, Devitt-Risse P, Fuchs HJ, Hurd DD.

Leuk Res. 2004 Jun;28(6):559-65.

PMID:
15120931
4.

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R, Pajak TF, Fleming TR, Henke M, Bourhis J, Rosenthal DI, Junor E, Cmelak A, Sheehan F, Pulliam J, Devitt-Risse P, Fuchs H, Chambers M, O'Sullivan B, Ang KK.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):674-81.

PMID:
14967419
5.

A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.

Kollef M, Pittet D, Sánchez García M, Chastre J, Fagon JY, Bonten M, Hyzy R, Fleming TR, Fuchs H, Bellm L, Mercat A, Mañez R, Martínez A, Eggimann P, Daguerre M, Luyt CE; Prevention of Pneumonia Study (POPS-1) Trial Group.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):91-7. Epub 2005 Sep 28.

PMID:
16192451
6.

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial.

Ferretti GA, Raybould TP, Brown AT, Macdonald JS, Greenwood M, Maruyama Y, Geil J, Lillich TT, Ash RC.

Oral Surg Oral Med Oral Pathol. 1990 Mar;69(3):331-8.

PMID:
2179802
7.
8.

Iseganan HCl: a novel antimicrobial agent.

Giles FJ, Redman R, Yazji S, Bellm L.

Expert Opin Investig Drugs. 2002 Aug;11(8):1161-70. Review.

PMID:
12150709
9.
10.
11.

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial.

Epstein JB, Silverman S Jr, Paggiarino DA, Crockett S, Schubert MM, Senzer NN, Lockhart PB, Gallagher MJ, Peterson DE, Leveque FG.

Cancer. 2001 Aug 15;92(4):875-85.

PMID:
11550161
13.

The effects of mouth rinses and dentifrice-containing magnesium monoperoxyphthalate (mmpp) on oral microflora, plaque reduction, and mucosa.

Scully C, El-Kabir M, Greenman J, Porter SR, Mutlu S, Barton I, Adair R.

J Clin Periodontol. 1999 Apr;26(4):234-8.

PMID:
10223394
14.

Effect of use of 0.05% cetylpyridinium chloride mouthwash on normal oral flora.

Radford JR, Beighton D, Nugent Z, Jackson RJ.

J Dent. 1997 Jan;25(1):35-40.

PMID:
9080738
15.

Antimicrobial therapy to prevent or treat oral mucositis.

Donnelly JP, Bellm LA, Epstein JB, Sonis ST, Symonds RP.

Lancet Infect Dis. 2003 Jul;3(7):405-12. Review. Erratum in: Lancet Infect Dis. 2003 Sep;3(9):598.

PMID:
12837345
16.

Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors.

Foncuberta MC, Cagnoni PJ, Brandts CH, Mandanas R, Fields K, Derigs HG, Reed E, Sonis ST, Fay J, LeVeque F, Pouillart P, Schrezenmeier H, Emmons R, Thiel E; Investigators in TGF-beta3/OM Study Protocols 203/205.

J Immunother. 2001 Jul-Aug;24(4):384-8.

PMID:
11565840
17.

A randomized, double-blind, placebo-controlled trial of misoprostol for oral mucositis secondary to high-dose chemotherapy.

Lalla RV, Gordon GB, Schubert M, Silverman S Jr, Hutten M, Sonis ST, LeVeque F, Peterson DE.

Support Care Cancer. 2012 Aug;20(8):1797-804. doi: 10.1007/s00520-011-1277-7. Epub 2011 Oct 1.

PMID:
21964618
18.

Microbiological outcomes of systemic ornidazole use in chronic periodontitis. Part II.

Pradeep AR, Kalra N, Priyanka N, Naik SB.

J Int Acad Periodontol. 2012 Apr;14(2):50-4.

PMID:
22799129
19.

Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse.

Weisdorf DJ, Bostrom B, Raether D, Mattingly M, Walker P, Pihlstrom B, Ferrieri P, Haake R, Goldman A, Woods W, et al.

Bone Marrow Transplant. 1989 Jan;4(1):89-95.

PMID:
2647192
20.
Items per page

Supplemental Content

Write to the Help Desk